EU Pharmaceutical Legislation Revisions: What Are the Implications for Biopharma? Anne Dhulesia Sean Dyson Read more
Podcast Life Sciences & Pharma Scope 3 Emissions: A Strategic Imperative for Pharma Companies May 8, 2024
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Executive Insights Mental and Behavioral Health Psychedelics and Psychotherapy: A Treatment Paradigm for the Future? March 27, 2024
Executive Insights Mental and Behavioral Health Mind-Altering Metamorphosis: Transforming the Patient Journey in Mental Health October 13, 2023